U.S. Arthritis Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

The U.S. Arthritis Therapies Markets provides an analysis of the BRMs, DMARDs, and NSAIDs segments between 2000 and 2010, with 2003 as the base year.

Table of Contents

U.S. Arthritis Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Arthritis Therapies Markets, Total U.S. Arthritis Therapies MarketOverviewIntroductionMethodologyMarket Overview and DefinitionReport Scope and Market SegmentationScope and SegmentationMarket Engineering Measurement Analysis for Total MarketMarket Demand and ForecastsIntroductionPatient ForecastsPricing ForecastsRevenue ForecastsCompetitive AnalysisCompetitive LandscapeMarket ShareIndustry Issues and ChallengesFrost and Sullivan AwardsCompany of the Year AwardTechnology Innovation AwardResearch and Development Excellence AwardU.S. Arthritis Therapies Markets, Biological Response Modifiers Arthritis Therapies MarketSegment HighlightsSegment HighlightsOverviewIntroductionBiologic Response Modifier Market Engineering Measurement AnalysisSegment IssuesMarket Demand and ForecastsRevenue Analysis and Market SizeMarket TrendsFactors Affecting Market GrowthProduct TrendsPricing TrendsCompetitive AnalysisCompetitive LandscapePipeline AnalysisMarket ShareU.S. Arthritis Therapies Markets, Non-Steroidal Anti-Inflammatory Drugs MarketSegment HighlightsSegment HighlightsOverviewIntroductionNon-Steroidal Anti-Inflammatory Drug Market Engineering Measurement AnalysisSegment IssuesMarket Demand and ForecastsRevenue Analysis and Market SizeMarket TrendsFactors Affecting Market GrowthProduct Trends IProduct Trends IIPricing TrendsCompetitive AnalysisCompetitive LandscapePipeline AnalysisMarket ShareU.S. Arthritis Therapies Markets, Disease-Modifying Anti-Rheumatic Drugs MarketSegment HighlightsSegment HighlightsOverviewIntroductionDisease Modifying Anti-Rheumatic Drug (DMARD) Arthritis Therapies Market Engineering Measurement AnalysisSegment IssuesMarket Demand and ForecastsRevenue Analysis and Market SizeMarket TrendsFactors Affecting Market GrowthProduct TrendsPricing TrendsCompetitive AnalysisCompetitive LandscapePipeline AnalysisMarket ShareU.S. Arthritis Therapies Markets, AppendixDecision Support DatabasesArthritis PrevalencePopulation 55 and aboveBiotechnology CompaniesHospital BedsObese Population




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.